Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.75 USD | +2.61% | -4.51% | -4.84% |
Feb. 12 | Acasti Pharma Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 | CI |
Feb. 07 | Craig-Hallum Initiates Acasti Pharma With Buy Rating, $6 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.84% | 25.19M | |
+33.77% | 664B | |
+29.29% | 567B | |
-7.42% | 354B | |
+18.83% | 330B | |
+4.54% | 286B | |
+13.79% | 234B | |
+4.93% | 199B | |
-9.78% | 196B | |
-4.82% | 148B |
- Stock Market
- Equities
- ACST Stock
- News Acasti Pharma Inc.
- Acasti Pharma to Implement 1-for-6 Reverse Stock Split